Click here to read this item in full if you are a subscriber to this newsletter
Our Shopping Cart is currently not working; please phone us on +44 870 1657210 in working hours (08.30 to 18.00 UK time) to place your order or, at other times, please email firstname.lastname@example.org specifying the Publication, Title and Issue date of the item you require.
Issue: September 2008, page: 4
ReGen Biologics raises funds, seeks approval for scaffold
Orthopaedics company ReGen Biologics Inc said it completed a US$2.5 million private placement of convertible notes and at the same time, submitted a new 510(k) application seeking clearance from the US Food and Drug Administration (FDA) of its collagen scaffold for reinforcement and repair of meniscus tissue.